Skip to content
drillr.ai
Sign up

CNSP

CNS Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.73
−2.66%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue(333.00)—3.3K4.1K11.8K
Gross Profit333.00—(3.3K)(4.1K)(11.8K)
Operating Expenses
R&D Expense10.1M9.8M9.3M14.1M9.3M
SG&A Expense6.8M6.2M5.6M4.8M5.6M
General & Admin Expense4.3M6.2M—4.8M—
Selling & Marketing Expense—————
Other Expenses—(0.00)—(4.1K)—
Total Operating Expenses16.9M16.0M14.9M18.9M14.9M
Cost and Expenses16.9M16.0M14.9M18.9M14.9M
Operating Income (EBIT)(16.9M)(16.0M)(14.9M)(18.9M)(14.9M)
Non-Operating
Interest Income232.9K153.8K60.3K27.7K—
Interest Expense14.9K15.2K16.1K13.8K7.0K
Net Interest Income217.9K138.6K44.1K13.9K(7.0K)
Other Non-Op Income/Expense215.4K136.0K44.1K13.9K(341.2K)
Non-Operating Income (excl Interest)(230.3K)(151.2K)(60.3K)(27.7K)334.1K
EBT (Pre-Tax Income)(16.7M)(15.9M)(14.9M)(18.9M)(15.3M)
Income Tax Expense—————
Bottom Line
Net Income(16.7M)(15.9M)(14.9M)(18.9M)(15.3M)
Earnings from Cont. Ops(16.7M)(15.9M)(14.9M)(18.9M)(15.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(16.7M)(15.9M)(14.9M)(18.9M)(15.3M)
Per Share
Basic EPS($23.59)($35.75)($466.44)($150,114.00)($336,499.00)
Diluted EPS($23.59)($35.75)($466.44)($150,114.00)($336,499.00)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding6.8M4433693185312645
Diluted Shares Outstanding6.8M4433693185312645
Profitability Metrics
EBITDA(16.6M)(15.8M)(14.8M)(18.8M)(15.3M)
D&A34.6K3.9K3.3K4.1K11.8K
EBIT(16.7M)(15.8M)(14.8M)(18.8M)(15.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026